Cargando…

The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials

Detalles Bibliográficos
Autores principales:	Abubakar, Ibrahim, Cobelens, Frank G. J., Rangaka, Molebogeng X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047458/ https://www.ncbi.nlm.nih.gov/pubmed/31816247 http://dx.doi.org/10.1164/rccm.201911-2258ED

Ejemplares similares

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?
por: Rangaka, Molebogeng X, et al.
Publicado: (2022)

The impact of COVID-19 on global tuberculosis control
por: Lipman, Marc, et al.
Publicado: (2021)

World TB Day 2018: The Challenge of Drug Resistant Tuberculosis
por: Gupta-Wright, Ankur, et al.
Publicado: (2018)

Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis
por: Gupta, Rishi K, et al.
Publicado: (2020)

Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?
por: Nelson, Kristin N, et al.
Publicado: (2023)

Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
por: Hamada, Yohhei, et al.
Publicado: (2021)

The cascade of care for latent tuberculosis infection in congregate settings: A national cohort analysis, Korea, 2017–2018
por: Min, Jinsoo, et al.
Publicado: (2022)

Tuberculosis Antigen-Specific T-Cell Responses During the First 6 Months of Antiretroviral Treatment
por: Riou, Catherine, et al.
Publicado: (2020)

Reply: Tuberculosis screening in migrants to the EU/EEA and UK
por: Zenner, Dominik, et al.
Publicado: (2023)

A Systematic Review on the Safety of Mycobacterium tuberculosis–Specific Antigen–Based Skin Tests for Tuberculosis Infection Compared With Tuberculin Skin Tests
por: Hamada, Yohhei, et al.
Publicado: (2023)

Noninferiority trials
por: Snapinn, Steven M
Publicado: (2000)

Declaration of Independence
Publicado: (1860)

The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges
por: Naidoo, Pren, et al.
Publicado: (2017)

End-point definition and trial design to advance tuberculosis vaccine development
por: Garcia-Basteiro, Alberto L., et al.
Publicado: (2022)

Post-trial access and the new version of the Declaration of Helsinki
por: Palacios, Ricardo
Publicado: (2013)

Understanding noninferiority trials
por: Hahn, Seokyung
Publicado: (2012)

The Dhaka Declaration 2015
por: Mahtab, Hajera, et al.
Publicado: (2015)

A declaration for all?
por: Couper, Ian
Publicado: (2019)

Altered Ratio of IFN-γ/IL-10 in Patients with Drug Resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome
por: Skolimowska, Keira H., et al.
Publicado: (2012)

An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study
por: Surey, J., et al.
Publicado: (2021)

Latent tuberculosis infection screening and treatment in congregate settings (TB FREE COREA): protocol for a prospective observational study in Korea
por: Min, Jinsoo, et al.
Publicado: (2020)

High prevalence of falsely declaring nicotine abstinence in lung transplant candidates
por: Veit, Tobias, et al.
Publicado: (2020)

Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial
por: Rangaka, Molebogeng X, et al.
Publicado: (2022)

Noninferiority Testing in Clinical Trials
por: Ng, Tie-Hua
Publicado: (2014)

New Diagnostics to Infer Risk in Tuberculosis: Is the Term “Latent Tuberculosis Infection” Obsolete?
por: Escalante, Patricio, et al.
Publicado: (2021)

Latent tuberculosis and the use of immunomodulatory agents
por: Aguiar, Fábio Silva, et al.
Publicado: (2019)

Latent tuberculosis infection and kidney transplantation
por: Tuon, Felipe Francisco
Publicado: (2021)

Defining the noninferiority margin and analysing noninferiority: An overview
por: Althunian, Turki A., et al.
Publicado: (2017)

Declaration of transparency for each research article
por: Altman, Douglas G, et al.
Publicado: (2013)

The San Francisco Declaration on Research Assessment
por: Cagan, Ross
Publicado: (2013)

The San Francisco Declaration on Research Assessment
por: Raff, Jordan W.
Publicado: (2013)

The African context of the Cape Town Declaration
por: Peter, Zilla, et al.
Publicado: (2018)

Ending tuberculosis in risk groups in Europe: challenges from travel and population movement
por: Jackson, Charlotte, et al.
Publicado: (2017)

Latent tuberculosis infection in foreign-born communities: Import vs. transmission in The Netherlands derived through mathematical modelling
por: Korthals Altes, Hester, et al.
Publicado: (2018)

C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study
por: Mendelson, Fiona, et al.
Publicado: (2018)

A user-centred design framework for mHealth
por: Farao, Jaydon, et al.
Publicado: (2020)

Correction: Latent tuberculosis infection in foreign-born communities: Import vs. transmission in The Netherlands derived through mathematical modelling
por: Korthals Altes, Hester, et al.
Publicado: (2018)

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
por: Mašić, Izet, et al.
Publicado: (2016)

Editorial: Statements, declarations and the problems of ethical expertise
por: Zwart, Hub
Publicado: (2007)

Dying Declaration: Musings from the Outgoing Editor
por: Ameen, Shahul
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bo7aor0vpmghj515p7jck2dapc